Drug-resistant Streptococcus pneumoniae

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1188-1195

  Campbell Jr , G Douglas ^a   Silberman, Ronald ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; PENICILLIN DERIVATIVE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 17344374327     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520286     Document Type: Article

References (26)

1. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults. Ann Intern Med 1988;108:616-25.
2. Schmidt LH, Sesler CL. Development of resistance to penicillin by pneumococci. Proc Soc Exp Biol Med 1943;52:353-7.
3. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967;2:264-5.
4. Hansman D, Devitt L, Miles H, Riley I. Pneumococci relatively insensitive to penicillin in Australia and New Guinea. Med J Aust 1974;2:353-6.
5. Gratten M, Naraqi S, Hansman D. High prevalence of penicillin-insensitive pneumococci in Port Moresby, Papua New Guinea. Lancet 1980;2:192-5.
6. Jacobs MR, Koornhof HJ, Robins-Browne RM, et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978;199:735-40.
7. Tomasz A. The pneumococcus at the gates. N Engl J Med 1995;333:514-5.
8. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
9. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 1997;24(suppl 1):S85-8.
10. Klugman KP. Pneumococcal resistance and antibiotics. Clin Microbiol Rev 1990;3:171-96.
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 4th ed. NCCLS Document M7-A4. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 1997.
12. Jacobs MR. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1992;15:119-27.
13. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J 1995;14:885-90.
14. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
15. Thomsberry C, Oglivie P, Kahn J, Mauriz Y, the Laboratory Investigator Group. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in the 1996-97 respiratory season: the Trust study. Diag Microbiol Infect Dis 1998 (in press).
16. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center National Surveillance Study. Antimicrob Agents Chemother 1996;40:1208-13.
17. Fairchok MP, Ashton WS, Fischer GW. Carriage of penicillin-resistant pneumococci in a military population in Washington, DC: risk factors and correlation with clinical disease. Clin Infect Dis 1996;22:966-72.
18. Hoffman J, Cetron MS, Parley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
19. Moreno S, García-Leoni ME, Cercenado E, Diaz MD, Bernaldo de Quirós JCL, Bouza E. Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study. Clin Infect Dis 1995;20:1195-200.
20. Marton A. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis 1992;15:106-11.
21. Bates J, Campbell GD Jr, Barron A, et al. Microbial etiology of acute pneumonia. Chest 1992;101:1005-12.
22. Niederman MS, Bass JB Jr, Campbell GD Jr, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26.
23. Campbell GD Jr, Niederman MS, Broughton WA, et al. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement. Am J Respir Crit Care Med 1996;153:1711-25.
24. Mandigers CM, Diepersloot RJ, Dessens M, Mol SJ, van Klingeren B. A hospital outbreak of penicillin-resistant pneumococci in the Netherlands. Eur Respir J 1994;7:1635-9.
25. Reichler MR, Rakovsky J, Sláčiková M, et al. Spread of multidrug-resistant Streptococcus pneumoniae among hospitalized children in Slovakia. J Infect Dis 1996;173:374-9.
26. Boschini A, Smacchia C, Di Fine M, et al. Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiology, and clinical aspects. Clin Infect Dis 1996;23:107-13.